A breast cancer patient with pelvic and gastric malignancy after adjuvant tamoxifen treatment for breast cancer.
As is known, tamoxifen therapy is related to endometrial proliferation, hyperplasia, polyp formation, invasive carcinoma and uterine sarcoma. In this study, we present a 75-year-old woman who had five children. Gastric tumor, endometrial carcinoma and cervical adenocarcinoma in situ were detected after treatment with tamoxifen for breast cancer. It seems that being aware of the undesirable affects of tamoxifen treatment during the chemotherapy and post-chemotherapy period is very important.
Dede
M
M
Department of Obstetrics and Gynecology, Gulhane Military Medical Academy, Ankara, Turkey.
Gezginç
K
K
Ulubay
M
M
Alanbay
I
I
Güran
S
S
Yenen
M
M
D000230:Adenocarcinoma / Q000139:chemically induced; D000368:Aged; D001943:Breast Neoplasms / Q000188:drug therapy*; D002278:Carcinoma in Situ / Q000139:chemically induced; D016889:Endometrial Neoplasms / Q000139:chemically induced; D005260:Female; D006801:Humans; D008875:Middle Aged; D020845:Selective Estrogen Receptor Modulators / Q000009:adverse effects*; D013274:Stomach Neoplasms / Q000139:chemically induced; D013629:Tamoxifen / Q000009:adverse effects*; D002583:Uterine Cervical Neoplasms / Q000139:chemically induced
D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen